Status:
COMPLETED
Adherence Connection for Counseling, Education, and Support (ACCESS) II
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
Jacobi Medical Center
Conditions:
HIV Infections
Eligibility:
All Genders
18-29 years
Phase:
NA
Brief Summary
The primary objective of the proposed clinical trial, Adherence Connection for Counseling, Education, and Support (ACCESS)-II, is to test the efficacy of ACCESS-II on antiretroviral treatment (ART) ad...
Detailed Description
To achieve these aims, a longitudinal (12 and 24- week study outcomes), two-group, randomized control trial (RCT) is proposed in a sample population of 120 perinatally and behaviorally, HIV-infected y...
Eligibility Criteria
Inclusion
- Inclusion criteria for participation in this study are:
- HIV seropositive status (perinatally and behaviorally infected youth)
- Ages 18-29 years
- English speaking
- Currently being prescribed an antiretroviral treatment regimen
- Evidence of virologic failure or (detectable quantitative HIV serum viral load\>200 copies/ml)
- No neuro-cognitive deficits which would impede participation in videoconferencing sessions or completion of study measures
Exclusion
Key Trial Info
Start Date :
February 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 25 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04499781
Start Date
February 14 2022
End Date
July 25 2024
Last Update
September 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacobi Medical Center
The Bronx, New York, United States, 10461